In a significant development, the British pharmaceutical giant AstraZeneca has made an announcement regarding the withdrawal of its anti-COVID-19 vaccine, "Vaxifria." According to sources within the health sector, the Ministry of Health in Kuwait has not obtained any doses of the AstraZeneca vaccine since late 2021 due to the absence of a contract. A representative from AstraZeneca mentioned, "Due to the development of numerous COVID-19 vaccines targeting different variants, there is now an excess supply of updated vaccines available." This surplus has resulted in a decrease in demand for Vaxifria, ultimately leading to its discontinuation in both manufacturing and supply.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Velit omnis animi et iure laudantium vitae, praesentium optio, sapiente distinctio illo?